LENZ logo

LENZ Therapeutics, Inc. (LENZ) EBIT

Annual EBIT:

-$58.61M+$13.82M(+19.08%)
December 31, 2024

Summary

  • As of today, LENZ annual earnings before interest & taxes is -$58.61 million, with the most recent change of +$13.82 million (+19.08%) on December 31, 2024.
  • During the last 3 years, LENZ annual EBIT has risen by +$1.83 million (+3.03%).
  • LENZ annual EBIT is now -202003.45% below its all-time high of -$29.00 thousand, reached on December 1, 2019.

Performance

LENZ EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLENZincome statement metrics

Quarterly EBIT:

-$18.89M-$2.03M(-12.04%)
September 30, 2025

Summary

  • As of today, LENZ quarterly earnings before interest & taxes is -$18.89 million, with the most recent change of -$2.03 million (-12.04%) on September 30, 2025.
  • Over the past year, LENZ quarterly EBIT has dropped by -$5.94 million (-45.90%).
  • LENZ quarterly EBIT is now -15509.09% below its all-time high of -$121.00 thousand, reached on March 1, 2020.

Performance

LENZ Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLENZincome statement metrics

TTM EBIT:

-$67.90M-$5.94M(-9.59%)
September 30, 2025

Summary

  • As of today, LENZ TTM earnings before interest & taxes is -$67.90 million, with the most recent change of -$5.94 million (-9.59%) on September 30, 2025.
  • Over the past year, LENZ TTM EBIT has increased by +$474.00 thousand (+0.69%).
  • LENZ TTM EBIT is now -56015.70% below its all-time high of -$121.00 thousand, reached on March 1, 2020.

Performance

LENZ TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLENZincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

LENZ EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+19.1%-45.9%+0.7%
3Y3 Years+3.0%+27.8%+30.6%
5Y5 Years-10000.0%-401.8%-1211.6%

LENZ EBIT Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+44.5%-49.7%+29.4%-15.8%+35.7%
5Y5-Year>-9999.0%+44.5%-401.8%+29.5%-1211.6%+35.7%
All-TimeAll-Time>-9999.0%+44.5%>-9999.0%+29.5%>-9999.0%+35.7%

LENZ EBIT History

DateAnnualQuarterlyTTM
Sep 2025
-
-$18.89M(-12.0%)
-$67.90M(-9.6%)
Jun 2025
-
-$16.86M(+0.4%)
-$61.96M(-4.2%)
Mar 2025
-
-$16.93M(-11.2%)
-$59.45M(-1.4%)
Dec 2024
-$58.61M(+19.1%)
-$15.22M(-17.6%)
-$58.61M(+14.3%)
Sep 2024
-
-$12.95M(+9.8%)
-$68.37M(+9.2%)
Jun 2024
-
-$14.35M(+10.8%)
-$75.29M(+0.8%)
Mar 2024
-
-$16.09M(+35.6%)
-$75.90M(-4.8%)
Dec 2023
-$72.43M(+31.4%)
-$24.99M(-25.8%)
-$72.43M(+2.4%)
Sep 2023
-
-$19.86M(-32.8%)
-$74.19M(+7.8%)
Jun 2023
-
-$14.96M(-18.6%)
-$80.48M(+12.8%)
Mar 2023
-
-$12.62M(+52.8%)
-$92.30M(+12.6%)
Dec 2022
-$105.64M
-
-
DateAnnualQuarterlyTTM
Dec 2022
-
-$26.75M(-2.3%)
-$105.64M(-8.0%)
Sep 2022
-
-$26.15M(+2.3%)
-$97.83M(-13.4%)
Jun 2022
-
-$26.78M(-3.2%)
-$86.28M(-12.0%)
Mar 2022
-
-$25.96M(-37.1%)
-$77.03M(-27.4%)
Dec 2021
-$60.44M(-347.7%)
-$18.94M(-29.7%)
-$60.44M(-21.3%)
Sep 2021
-
-$14.60M(+16.7%)
-$49.83M(-27.8%)
Jun 2021
-
-$17.53M(-87.2%)
-$38.99M(-71.4%)
Mar 2021
-
-$9.37M(-12.6%)
-$22.75M(-68.5%)
Dec 2020
-$13.50M(>-9900.0%)
-$8.32M(-121.1%)
-$13.50M(-160.8%)
Sep 2020
-
-$3.76M(-191.3%)
-$5.18M(-266.4%)
Jun 2020
-
-$1.29M(-967.8%)
-$1.41M(-1067.8%)
Mar 2020
-
-$121.00K
-$121.00K
Dec 2019
-$29.00K
-
-

FAQ

  • What is LENZ Therapeutics, Inc. annual earnings before interest & taxes?
  • What is the all-time high annual EBIT for LENZ Therapeutics, Inc.?
  • What is LENZ Therapeutics, Inc. annual EBIT year-on-year change?
  • What is LENZ Therapeutics, Inc. quarterly earnings before interest & taxes?
  • What is the all-time high quarterly EBIT for LENZ Therapeutics, Inc.?
  • What is LENZ Therapeutics, Inc. quarterly EBIT year-on-year change?
  • What is LENZ Therapeutics, Inc. TTM earnings before interest & taxes?
  • What is the all-time high TTM EBIT for LENZ Therapeutics, Inc.?
  • What is LENZ Therapeutics, Inc. TTM EBIT year-on-year change?

What is LENZ Therapeutics, Inc. annual earnings before interest & taxes?

The current annual EBIT of LENZ is -$58.61M

What is the all-time high annual EBIT for LENZ Therapeutics, Inc.?

LENZ Therapeutics, Inc. all-time high annual earnings before interest & taxes is -$29.00K

What is LENZ Therapeutics, Inc. annual EBIT year-on-year change?

Over the past year, LENZ annual earnings before interest & taxes has changed by +$13.82M (+19.08%)

What is LENZ Therapeutics, Inc. quarterly earnings before interest & taxes?

The current quarterly EBIT of LENZ is -$18.89M

What is the all-time high quarterly EBIT for LENZ Therapeutics, Inc.?

LENZ Therapeutics, Inc. all-time high quarterly earnings before interest & taxes is -$121.00K

What is LENZ Therapeutics, Inc. quarterly EBIT year-on-year change?

Over the past year, LENZ quarterly earnings before interest & taxes has changed by -$5.94M (-45.90%)

What is LENZ Therapeutics, Inc. TTM earnings before interest & taxes?

The current TTM EBIT of LENZ is -$67.90M

What is the all-time high TTM EBIT for LENZ Therapeutics, Inc.?

LENZ Therapeutics, Inc. all-time high TTM earnings before interest & taxes is -$121.00K

What is LENZ Therapeutics, Inc. TTM EBIT year-on-year change?

Over the past year, LENZ TTM earnings before interest & taxes has changed by +$474.00K (+0.69%)
On this page